IL1B and diabetes mellitus: The BALF and tissue TNF-α, IL-6, and IL-1β levels in diabetic rats were more than Group Control, and those levels were significantly lower after CC treatment than those in group diabetes (p < 0.001) in comparison with the healthy rats, the IL-10 level was reduced in group diabetes, and significant increase were found in the group receiving the CC (Figures 5 and 6).